IM Cannabis Enters Non-Binding Agreement to Acquire 51% of Space Defense Innovations, Operating in the European Tactical UAS Market

Deal overview

IM Cannabis (IMCC) announced a non-binding Letter of Intent to acquire 51% of the issued and outstanding equity of Space Defense Innovations LLC (SDI), a Polish company active in unmanned aerial systems (UAS). SDI operates through a wholly owned subsidiary, BlueAero Group Sp. z o.o., as a reseller of BlueBird Aero Systems' tactical UAS and, subject to regulatory licenses, is expected to become a manufacturer of those products in Europe with exclusivity in Poland. The parties aim to sign definitive agreements within 60 days.

Sources: S1

Terms disclosed in the LOI

Under the LOI IMCC would acquire 51% of SDI for a combination of IMCC common shares and/or pre-funded warrants (with a cap so no SDI shareholder would beneficially own more than 19.99% of IMCC), plus a 24-month seller loan bearing 9% annual interest with 100% warrant coverage. IMCC will also receive a five-year call option to acquire the remaining SDI shares at the same valuation, the right to appoint a majority of SDI's board, and will provide an on-demand line of credit of up to EUR 2.3 million (36-month maturity) convertible at IMC's discretion into SDI shares, subject to a minimum company valuation of no less than US$5 million supported by an independent valuation report.

Sources: S1

Conditions, timing and binding provisions

The LOI is non-binding except for customary confidentiality, exclusivity and governing law provisions. Closing is conditioned on satisfactory due diligence at IMCC's sole discretion, negotiation of definitive agreements, receipt of required approvals, assignment of key commercial agreements and other customary conditions. The press release notes there can be no assurance that definitive agreements will be signed or the transaction completed.

Sources: S1

Context and inferred rationale

IMCC framed the potential transaction as aligning with its stated objective to evaluate and build technology-driven businesses beyond its core medical cannabis operations in Israel and Germany. SDI's targeted products include VTOL ISR platforms, loitering munitions and 3D mapping capabilities, leveraging BlueBird's ISO 9001:2015 certified capabilities in engineering and software. These product and capability descriptions come from IMCC's release and reflect the companies' representations.

Sources: S1

What remains uncertain

• The LOI is explicitly non-binding except for limited provisions; the press release states there can be no assurance that definitive agreements will be signed or that the proposed transaction will be completed.
• SDI becoming a manufacturer in Europe is described as contingent on receipt of applicable regulatory licenses and is presented as an expectation by the parties, not an accomplished fact.
• Closing is subject to satisfactory due diligence at IMCC's sole discretion and to corporate, governmental and third-party approvals; these conditions create substantial execution risk.